A new sort of Alzheimer’s drug shows glimmers of promise
The experimental drug lowered tau levels and showed small improvements in memory loss
An experimental drug targets tau (seen in blue in this illustration), a protein that forms toxic tangles in Alzheimer’s disease. Other recently approved drugs target the buildup of amyloid plaques (brown).
National Institute on Aging/NIH